platoseedplatoseed
Empowering every doctor and every patient to participate in research
Novelcare addresses the primary bottleneck in drug development: recruiting patients into clinical trials. We analyze electronic health records to help doctors find clinical trials for their patients, and to help trial sites find patients for their studies. 72% of doctors want to inform their patients of clinical trials, but only 5% do. We're on a mission to close that gap, ultimately bringing safer, more effective drugs to the patients who need them.
Novelcare connects patients to relevant care options by informing doctors about locally available, medically relevant treatment options. It aims to integrate new treatments into clinicians' workflows with HIPAA-compliant security and zero-cost access for most practices.
The product automatically sends study information to patients identified as relevant, enabling physicians to offer cutting-edge treatments without altering their clinical workflow. It emphasizes HIPAA compliance, security, and a model where patients access new treatments at zero cost, with potential revenue through chart review for some studies.
Who it’s for: Healthcare providers (doctors, clinics, and healthcare organizations) looking to offer new treatments and connect patients to relevant clinical studies or care options.
Website mentions pricing page and a demo; references to trust, CEO letter, and FAQ sections indicate ongoing product maturation and potential user acquisition efforts.
Ethan is the co-founder and CEO of SelectIQ. Prior to SelectIQ, Ethan was a product strategist at Palantir where he led product development into multiple new verticals, most recently helping to build Palantir's nascent life sciences division. Ethan is a product designer and software engineer by training, having *almost* graduated from Rensselaer Polytechnic Institute.
Jason is the co-founder and CTO of SelectIQ. Prior to SelectIQ, Jason worked at Palantir on life sciences software and led Palantir's Data Governance product team. Previously, he co-founded Skylight, an NYC real estate app acquired by Common Living. He's also a 2015 Thiel Fellow.
Formerly “Recomp”, “Resync”, “Workpage”, “SelectIQ” · why startups rename →
AI-powered Patient Identification for Clinical Trials
Accelerate clinical trials with real-time, actionable insights
